A suplementação de arginina é efetiva em prevenir pré-eclâmpsia em gestantes?
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2022.184348Palavras-chave:
Gravidez, Arginina, Pré-eclâmpsia, Suplementação, Óxido nítricoResumo
Objetivo: O objetivo deste estudo foi revisar dados de ensaios clínicos randomizados para avaliar se a suplementação de L-Arginina é efetiva para reduzir a incidência de pré-eclâmpsia em gestantes com alto risco de desenvolver a doença.
Métodos: Realizamos uma revisão sistemática de ensaios clínicos randomizados, incluindo aqueles que compararam a suplementação de L-Arginina com placebo em gestantes de alto risco de desenvolvimento de pré-eclâmpsia, analisando a incidência de pré-eclâmpsia como desfecho principal. Os estudos foram selecionados do MEDLINE/ Pubmed, EMBASE/ Elsevier, LILACS/ BVS e Cochrane.
Resultados: Um total de 46 estudos foram identificados na busca primária. Após análise da elegibilidade, dos critérios de inclusão e de exclusão, dois artigos (que respeitaram em detalhes todas etapas de avaliação) foram incluídos na presente revisão. Foi realizada uma avaliação de risco de viés. A análise dos dados revelou que a incidência de pré-eclâmpsia foi significativamente menor em ambos os estudos, e nenhum efeito adverso importante foi relatado. As limitações deste estudo foram a falta de padronização entre os ensaios clínicos analisados e o número relativamente baixo de estudos incluídos.
Conclusão: A suplementação com L-Arginina parece reduzir a incidência de pré-eclâmpsia em gestantes de alto risco para seu desenvolvimento.
Downloads
Referências
Wu G, Imhoff-Kunsch B, Girard AW. Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatric and Perinatal Epidemiology. John Wiley & Sons, Ltd [Internet]. 2012 [cited 2020 Aug 25]; 26:4-26. Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-3016.2012.01291.x
Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids [Internet]. 2009 [cited 2020 Aug 25]; 37:153–68. Available at: https://link.springer.com/article/10.1007/s00726-008-0210-y
Morris SM. Arginine metabolism revisited. J Nutr [Internet]. 2016 Dec 1 [cited 2020 Aug 25]; 146(12):2579S-2586S. Available at: https://academic.oup.com/jn/article/146/12/2579S/4589950
Puga GM, Novais I de P, Zanesco A. Efeitos terapêuticos da suplementação de L-arginina nas doenças cardiovasculares e endócrino-metabólicas. Arquivos de Medicina [Internet]. 2011 [cited 2020 Aug 25]; 25(3):107-114. Available at: http://hdl.handle.net/11449/72416
Cabral CHA, de Almeida DM, Martins LS, Mendes RKV. Mecanismos fisiológicos e bioquímicos envolvidos no turnover protéico: deposição e degradação de proteína muscular. Enciclopédia Biosfera, Centro Científico Conhecer, Goiânia [Internet]. 2012 [cited 2020 Aug 25];8(15):1185-1203. Available at: https://conhecer.org.br/ojs/index.php/biosfera/article/view/3693
Fuhrmann J, Clancy KW, Thompson PR. Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation. Chemical Reviews. American Chemical Society [Internet]. 2015 [cited 2020 Aug 25]; 115:5413–61. Available at: https://pubs.acs.org/sharingguidelines
Landim MBP, Casella Filho A, Chagas ACP. Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: Implications for atherogenesis. Clinics. Faculdade de Medicina / USP [Internet]. 2009 [cited 2020 Aug 25]; 64:471–8. Available at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009000500015&lng=en&nrm=iso&tlng=en
Neves JA, Neves JA, Oliveira R de CM. Biomarcadores de função endotelial em doenças cardiovasculares: Hipertensão. Jornal Vascular Brasileiro. Sociedade Brasileira de Angiologia e Cirurgia Vascular [Internet]. 2016 [cited 2020 Aug 25]; 15:224–33. Available at: http://dx.doi.org/10.1590/1677-5449.000316
Ignarro LJ. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension [Internet]. 1990 [cited 2021 May 28]; 16(5):477–83. Available at: https://www.ahajournals.org/doi/10.1161/01.hyp.16.5.477
Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov [Internet]. 2008 Feb [cited 2021 May 28]; 7:156–67. Available at: https://www.nature.com/articles/nrd2466
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature [Internet]. 1980 Nov 27 [cited 2021 May 28]; 288:373–6. Available at: https://www.nature.com/articles/288373a0
Moncada S, Radomski MW, Palmer RM. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol [Internet]. 1988 Jul 1 [cited 2021 May 28]; 37(13):2495–501. Available at: https://pubmed.ncbi.nlm.nih.gov/3291879/
Huang L-T, Hsieh C-S, Chang K-A, Tain Y-L. Roles of Nitric Oxide and Asymmetric Dimethylarginine in Pregnancy and Fetal Programming. Int J Mol Sci [Internet]. 2012 Nov 9 [cited 2020 Aug 25]; 13(12):14606–22. Available at: http://www.mdpi.com/1422-0067/13/11/14606
Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol [Internet]. 1997 Feb [cited 2021 May 28]; 272:(2 Pt 2):R441-63. Available at: https://pubmed.ncbi.nlm.nih.gov/9124465/
Bode-Böger SM, Scalera F, Ignarro LJ. The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacology and Therapeutics. Pharmacol Ther [Internet]. 2007 [cited 2020 Aug 25]; 114:295–306. Available at: https://pubmed.ncbi.nlm.nih.gov/17482266/
Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch-Eur J Physiol [Internet]. 2010 [cited 2020 Aug 25]; 459:923–39. Available at: https://link.springer.com/article/10.1007/s00424-010-0808-2
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet [Internet]. 2019 May 20 [cited 2021 May 28]; 145(supl 1):1–33. Available at: https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.12802
Dymara-Konopka W, Laskowska M. The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review. Int J Mol Sci [Internet]. 2019 jun 5 [cited 2020 Aug 25]; 20(11):2757. Available at: https://www.mdpi.com/1422-0067/20/11/2757
Dusse LM, Alpoim PN, Lwaleed BA, de Sousa LP, Carvalho MG, Gomes KB. Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia? Clin Chim Acta [Ingernet]. 2013 Jan 16 [cited 2021 May 28]; 415:226–9. Available at: https://doi.org/10.1016/j.cca.2012.10.006
Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: Randomised controlled trial. BMJ [Internet]. 2011 May 28 [cited 2020 Aug 25];342(7808). Available at: https://pubmed.ncbi.nlm.nih.gov/21596735/
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine. BMJ [Internet]. 2009 [cited 2020 Aug 25]; 339:b2700. Available at: https://www.bmj.com/content/339/bmj.b2700
Santos CMC, Pimenta CAM, Nobre MRC. The PICO strategy for the research question construction and evidence search [Internet]. Rev. Latino-Am Enfermagem. 2007 Jun [cited 2020 Aug 25]; 15(3):508–11. Available at: https://doi.org/10.1590/S0104-11692007000300023
Diretrizes metodológicas: elaboração de revisão sistemática e metanálise de ensaios clínicos randomizados [Internet]. Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia. – Brasília: Editora do Ministério da Saúde. 2012 [cited 2020 Aug 25]. Available at: http://digital.bibliotecaorl.org.br/handle/forl/412
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ [Internet]. 2011 Oct 29 [cited 2020 Aug 25];343(7829). Available at: https://www.bmj.com/content/343/bmj.d5928
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP Classification, Diagnosis and Management Recommendations for International Practice. International Society for the Study of Hypertension in Pregnancy and the American Heart Association. Hypertension [Internet]. 2018 [cited 2020 Aug 25]; 72: 24–43. Available at: https://doi.org/10.1161/HYPERTENSIONAHA.117.10803
Camarena Pulido EE, García Benavides L, Panduro Barón JG, Pascoe Gonzalez S, Madrigal Saray AJ, García Padilla FE, et al. Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies: A double-blind, randomized, clinical trial. Hypertens Pregnancy [Internet]. 2016 April 2 [cited 2020 Aug 25];35(2):217–25. Available at: https://pubmed.ncbi.nlm.nih.gov/27003763/
Zullino S, Buzzella F, Simoncini T. Nitric oxide and the biology of pregnancy [Internet]. Vascular Pharmacology [Internet]. 2018 [cited 2020 Aug 25]; 110:71–4. Available at: https://pubmed.ncbi.nlm.nih.gov/30076925/
Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular development and function. Placenta [Internet]. 2011 Nov [cited 2021 May 28]; 32(11):797–805. Available at: https://doi.org/10.1016/j.placenta.2011.06.025
Demir B, Demir S, Pasa S, Guven S, Atamer Y, Atamer A, et al. The role of homocysteine, asymmetric dimethylarginine and nitric oxide in preeclampsia. J Obstet Gynaecol [Internet]. 2012 Aug [cited 2020 Aug 25]; 32(6):525–8. Available at: https://www.tandfonline.com/doi/abs/10.3109/01443615.2012.693985
Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide - Biol Chem [Internet]. 2000 [cited 2020 Aug 25]; 4(4):441–58. Available at: https://doi.org/10.1006/niox.2000.0296
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia. J Clin Invest [Internet]. 2003 Mar 1 [cited 2020 Aug 25]; 111(5):649–58. Available at: https://doi.org/10.1172/JCI17189
Seki H. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. Acta Obstet Gynecol Scand [Internet]. 2014 Oct 1 [cited 2020 Aug 25]; 93(10):959–64. Available at: http://doi.wiley.com/10.1111/aogs.12473
Bergen NE, Jaddoe VWV, Timmermans S, Hofman A, Lindemans J, Russcher H, et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: The generation R study. BJOG An Int J Obstet Gynaecol [Internet]. 2012 May 1 [cited 2020 Aug 25]; 119(6):739–51. Available at: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/j.1471-0528.2012.03321.x
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med [Internet]. 2017 Aug 17 [cited 2020 Dec 6]; 377(7):613–22. Available at: https://www.nejm.org/doi/full/10.1056/nejmoa1704559
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Gabriel Leite Citrangulo, Ana Luísa Scafura da Fonseca, Pedro Viana Diniz, João Pedro Torres Neiva Rodrigues, Denise Gasparetti Drumond
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.